Diabetic polyneuropathy: diagnosis, prevention, and treatment

The most common form of peripheral nervous system damage in diabetes mellitus is distal symmetric sensorimotor polyneuropathy (DSSMPN). Chronic hyperglycemia, dyslipidemia, and impaired microcirculation are considered to be the key mechanisms for the development of DSSMPN, but its pathogenesis is st...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Неврология, нейропсихиатрия, психосоматика
المؤلفون الرئيسيون:	V. A. Golovacheva, I. A. Strokov
التنسيق:	مقال
اللغة:	الروسية
منشور في:	IMA-PRESS LLC 2020-08-01
الموضوعات:	diabetic polyneuropathy polyneuropathy diagnosis treatment alpha-lipoic acid thioctic acid
الوصول للمادة أونلاين:	https://nnp.ima-press.net/nnp/article/view/1425

مواد مشابهة

Early diagnosis and treatment of diabetic and alcoholic polyneuropathy in outpatient practice
حسب: V. A. Golovacheva
منشور في: (2020-12-01)

α-Lipoic acid as the main pharmacological drug for in- and outpatient treatment of diabetic polyneuropathy
حسب: I. A. Strokov, وآخرون
منشور في: (2016-12-01)

DIABETIC POLYNEUROPATHY: PATHOGENESIS, CLINICAL PRESETATION AND NEW APPROACHES TO PERSONALIZED TREATMENT
حسب: M. M. Tanashyan, وآخرون
منشور في: (2017-11-01)

Alcoholic polyneuropathy: ways of diagnostics and therapy
حسب: O. V. Kurushina, وآخرون
منشور في: (2019-03-01)

DIABETIC POLYNEUROPATHY: CURRENT APPROACHES TO DIAGNOSIS AND PATHOGENETIC THERAPY
حسب: O. S. Levin
منشور في: (2014-07-01)

MARKERS OF PERIPHERAL NERVOUS SYSTEM LESION IN DIABETES MELLITUS
حسب: О. V. Kurushina, وآخرون
منشور في: (2017-07-01)

Influence of thioctic acid in patients with diabetes mellitus or newly diagnosed diabetes mellitus in combination with diabetic polyneuropathy after anterior septal Q wave myocardial infarction on the prevention of hypertrophy and structural myocardial remodeling
حسب: K. G. Yanovky, وآخرون
منشور في: (2023-07-01)

Diabetic polyneuropathy: from science to practice
حسب: V. A. Golovacheva, وآخرون
منشور في: (2015-12-01)

Pathogenesis, evaluation and pathogenetic therapy of diabetic polyneuropathy
حسب: I. A. Strokov, وآخرون
منشور في: (2021-06-01)

Diabetic polyneuropathy: a current algorithm for patient management
حسب: L. T. Akhmedzhanova, وآخرون
منشور في: (2019-06-01)

Role of pathogenetic therapy for diabetic polyneuropathy
حسب: D. A. Iskra, وآخرون
منشور في: (2021-02-01)

Evaluation of effectiveness of different modes of per os therapy of painful diabetic peripheral polyneuropathy with alpha-lipoic acid
حسب: Vladimir Nikolaevich Khramilin, وآخرون
منشور في: (2010-06-01)

«Masks» of alcoholic polyneuropathy
حسب: N. V. Pizova
منشور في: (2020-04-01)

THE PROBLEMS OF THE PATHOGENESIS AND TREATMENT OF ALCOHOLIC POLYNEUROPATHY
حسب: O. E. Zinov'eva, وآخرون
منشور في: (2009-06-01)

Main metabolic and toxic polyneuropathies in clinical practice
حسب: N. V. Pizova
منشور في: (2021-12-01)

Diabetic polyneuropathy: what's new?
حسب: E. G. Demianovskaya, وآخرون
منشور في: (2025-03-01)

Diabetic neuropathy in combination with deficiency state
حسب: O. E. Zinovyeva, وآخرون
منشور في: (2022-03-01)

Modern principles of diagnosis and treatment of diabetic polyneuropathy
حسب: I. A. Strokov, وآخرون
منشور في: (2014-12-01)

Cognitive impairment and distal polyneuropathy in a patient with diabetes mellitus in neurological outpatient practice
حسب: O. V. Kosivtsova, وآخرون
منشور في: (2020-06-01)

Use of parenteral vitamin B complexes in treatment of polyneuropathy
حسب: O. V. Kurushina, وآخرون
منشور في: (2018-11-01)

Management of patients with diabetic polyneuropathy: current guidelines for diagnosis and treatment, prospects for pharmacotherapy
حسب: V. A. Golovacheva, وآخرون
منشور في: (2015-12-01)

Management of patients with neurological complications of diabetes mellitus
حسب: O. V. Kosivtsova, وآخرون
منشور في: (2020-12-01)

Differential diagnosis of polyneuropathies in diabetes mellitus
حسب: V. N. Khramilin
منشور في: (2021-09-01)

Electroneuromyography for early diagnosis of diabetic distal polyneuropathy
حسب: Elena S. Mazurenko, وآخرون
منشور في: (2019-06-01)

Effects of Short-Term Treatment with α-Lipoic Acid on Neuropathic Pain and Biomarkers of DNA Damage in Patients with Diabetes Mellitus
حسب: Juozas R. Lazutka, وآخرون
منشور في: (2024-11-01)

Management of patients with painful diabetic neuropathy: clinical case report
حسب: V. A. Golovacheva, وآخرون
منشور في: (2021-01-01)

Principles of Treatment of Patients with Diabetic Polyneuropathy in the COVID-19 Pandemic
حسب: V. A. Golovacheva, وآخرون
منشور في: (2021-12-01)

Alpha-Lipoic Acid in Diabetic Peripheral Neuropathy: Addressing the Challenges and Complexities Surrounding a 70-Year-Old Compound
حسب: Iliya Mangarov, وآخرون
منشور في: (2025-05-01)

Current aspects of treatment of diabetic polyneuropathy in patients with diabetes
حسب: А. S. Ametov, وآخرون
منشور في: (2016-12-01)

Lumbosacral motor polyneuropathy
حسب: S. A. Malmberg, وآخرون
منشور في: (2015-02-01)

Modern Approaches to the Technology of Tablet Dosage Forms of Thioctic Acid (Review)
حسب: S. N. Egorova, وآخرون
منشور في: (2021-05-01)

Diabetic polyneuropathy: pathogenesis, classification, clinical presentation, and treatment
حسب: Marina Valentinovna Nesterova, وآخرون
منشور في: (2013-11-01)

Diabetic distal polyneuropathy: prevention, treatment and rehabilitation (review)
حسب: A. M. Morozov, وآخرون
منشور في: (2022-07-01)

Diabetic polyneuropathy: efficacy of Actovegin
حسب: I. A. Strokov, وآخرون
منشور في: (2013-12-01)

ELECTRONEUROMYOGRAPHY EXAMINATION OF DIABETIC POLYNEUROPATHY PATIENTS
حسب: Siti Nurlaela, وآخرون
منشور في: (2019-01-01)

Prevalence and characteristics of diabetic symmetric sensorimotor polyneuropathy in Japanese patients with type 2 diabetes: The Japan Diabetes Complication and its Prevention Prospective study (JDCP study 10)
حسب: Hideki Kamiya, وآخرون
منشور في: (2024-02-01)

The usefulness of ultrasonography for the early diagnosis of polyneuropathy in patients with type II diabetes mellitus
حسب: Amrendra Kumar Mahato, وآخرون
منشور في: (2024-05-01)

TREATMENT OF DIABETIC DISTAL POLYNEUROPATHY WITH ACTOVEGIN® IN TYPE 2 DIABETIC PATIENTS.
حسب: E. U. Komelyagina, وآخرون
منشور في: (2017-07-01)

The prevalence and risk factors of diabetic polyneuropathy in inpatients with type 1 diabetes
حسب: I. A. Strokov, وآخرون
منشور في: (2015-02-01)

Nonpharmaceutical treatment of distal sensorimotor polyneuropathy in diabetic patients: an unblinded randomized clinical trial
حسب: Alexandra Strobel, وآخرون
منشور في: (2025-03-01)